Micropore Closure Rates following Microneedle Application at Various Anatomical Sites in Healthy Human Subjects

Abayomi Tolulope Ogunjimi1, Christine Lawson1, Jamie Carr1

  • 1Department of Pharmaceutical Sciences and Experimental Therapeutics, University of Iowa College of Pharmacy, Iowa City, Iowa, USA.

Abstract

Insights

Micropore closure time after microneedle (MN) application varied slightly across anatomical sites, with the abdomen showing the longest duration. These findings suggest anatomical site may not significantly impact MN drug delivery strategies.

Area of Science:

  • Dermatology
  • Biomedical Engineering
  • Pharmacology

Background:

  • Continuous availability of open micropores is essential for microneedle (MN) drug delivery.
  • Micropore lifetime is influenced by intrinsic skin characteristics, which differ across anatomical sites.

Purpose of the Study:

  • To investigate potential differences in micropore closure timeframes at the upper arm, volar forearm, and abdomen.
  • To assess the impact of anatomical location on microneedle-mediated drug delivery efficacy.

Main Methods:

  • Healthy subjects (n=35) underwent microneedle treatment on the upper arm, volar forearm, and abdomen.
  • Skin impedance and transepidermal water loss (TEWL) were measured to confirm micropore formation.
  • Impedance measurements over 3 days, along with mathematical modeling, were used to determine micropore closure half-life.

Main Results:

  • Micropore formation was confirmed by significant increases in TEWL and decreases in impedance across all sites.
  • The abdomen exhibited the longest mean micropore closure time (63.09 ± 13.13 h), followed by the upper arm and volar forearm.
  • Predicted micropore closure half-lives were longest for the abdomen (25.86 ± 14.96 h) and upper arm (23.69 ± 13.67 h) compared to the volar forearm (20.2 ± 11.99 h).
  • Darker skin tones (L* values) showed a potential association with longer micropore closure times at the abdomen.

Conclusions:

  • Anatomical site of application does not appear to be a major source of variability in micropore closure time.
  • These findings can simplify the development of drug products for microneedle-assisted drug delivery by reducing the number of physiological parameters to consider.

Related Concept Videos